首页> 外文期刊>Annals of Clinical Microbiology and Antimicrobials >Enzyme-mediated formulation of stable elliptical silver nanoparticles tested against clinical pathogens and MDR bacteria and development of antimicrobial surgical thread
【24h】

Enzyme-mediated formulation of stable elliptical silver nanoparticles tested against clinical pathogens and MDR bacteria and development of antimicrobial surgical thread

机译:酶介导的稳定椭圆形银纳米颗粒制剂针对临床病原体和MDR细菌的测试以及抗菌手术线的开发

获取原文
           

摘要

Background Silver nanoparticles (AgNPs) are believed to be emerging tool against various infectious diseases including multi-drug resistant (MDR) bacteria. In the present study, in vitro synthesis of AgNPs was optimized using 1:50 ratio of macerozyme (25?μg/μl) and 1?mM AgNO3 incubated at 80?°C for 8?h. AgNPs were characterized by UV–Visible spectroscopy, dynamic light scattering (DLS), scanning electron microscopy, energy-dispersive X-ray spectroscopy, transmission electron microscopy (TEM) and X-ray diffraction (XRD). Results Characterization studies suggest the synthesis of elliptical, stable and crystalline AgNPs with an average size of 38.26?±?0.4?nm calculated using TEM. The XRD pattern revealed the face-centered-cubic (fcc) form of metallic silver. Good shape integrity and dispersion of AgNPs after 1?year of incubation confirmed their stability. AgNPs were exibited the antimicrobial property against ten pathogenic bacteria, three molds and one yeast. The AgNPs also revealed remarkable antimicrobial activity against three MDR strains i.e. Extended spectrum beta-lactamase positive Escherichia coli , Staphylococcus aureus (MRSA) and Teicoplanin resistant Streptococcus Pneumoniae. The AgNPs coated surgical threads (suture) were revealed the remarkble antibacterial activity against three MDR strains. This is the first report to synthesize antimicrobial elliptical AgNPs using enzymes. Conclusion The results suggest the possibilities to develop the nanoparticles coated antimicrobial medical fabric to combat against MDR infection.
机译:背景技术银纳米颗粒(AgNPs)被认为是针对各种传染病(包括耐多药(MDR)细菌)的新兴工具。在本研究中,使用在80?C孵育8?h的1:50比例的微溶菌酶(25?μg/μl)和1?mM AgNO 3 优化了AgNPs的体外合成。 AgNPs的特征在于紫外可见光谱,动态光散射(DLS),扫描电子显微镜,能量色散X射线光谱,透射电子显微镜(TEM)和X射线衍射(XRD)。结果表征研究表明,使用TEM计算可合成平均大小为38.26?±?0.4?nm的椭圆形,稳定和结晶的AgNP。 XRD图谱显示了金属银的面心立方(fcc)形式。孵育1年后,AgNP的良好形状完整性和分散性证实了它们的稳定性。 AgNPs具有十种致病菌,三种霉菌和一种酵母的抗菌特性。 AgNPs还显示出对三种MDR菌株的显着抗菌活性,即扩展谱的β-内酰胺酶阳性大肠杆菌,金黄色葡萄球菌(MRSA)和耐替考拉宁的肺炎链球菌。用AgNPs包被的手术线(缝合线)显示出对三种MDR菌株的显着抗菌活性。这是使用酶合成抗菌椭圆形AgNP的第一份报告。结论结果表明开发纳米涂层的抗微生物医用织物以对抗MDR感染的可能性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号